By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Dec 1, 2022/CPG
Lateral Elbow Pain and Muscle Function Impairments: Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability and Health from the Academy of Hand and Upper Extremity Physical Therapy and the Academy of Orthopaedic Physical Therapy of the American Physical Therapy
Jun 28, 2024/Article
Documentation elements for the initial examination and evaluation include the following: examination, evaluation, diagnosis, prognosis, intervention, and outcomes.
Apr 1, 2024/Feature
What APTA is doing to address DEI in 2024 and beyond.
APTA advocates can report their meetings and interactions with members of Congress and their staff using the form below. Meeting feedback and information is critical for the APTA Government Affairs team to further connect and follow up with legislators and their staff in their work on Capitol Hill. Questions?
Nov 1, 2022/Feature
Leadership thrives on communication and collaboration. That's the core concept behind the association's new APTA Leadership Congress event.
Sep 5, 2025/News
Congress is beginning to formally investigate ongoing issues with the TRICARE system that have affected health care providers and military families who rely on the program for coverage and care.
Podcast
Experts discuss injury prevention concerns, COVID-19 and safe practice and play considerations, and gave recommendations for preparation and implementation of sports activities in the upcoming phases of reopening.
Sep 20, 2019/Policies & Bylaws
House position: APTA supports the following health priorities for populations and individuals in the areas of prevention, wellness, fitness, health promotion, and management of disease and disability.
Feb 4, 2021/Members Only
Topics discussed: FY2022 SNF, IRF, and IPPS rules, VA and HIPAA rules, telehealth update, Info blocking, Wellness Programs, and commercial payer updates.
Mar 31, 2015/CPG
The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.